Northern Financial Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.19M Sell
4,699
-43
-0.9% -$10K 0.79% 35
2026
Q1
$1.16M Buy
4,742
+2,437
+106% +$568K 0.85% 37
2025
Q4
$477K Sell
2,305
-1,940
-46% -$384K 0.55% 55
2025
Q3
$787K Buy
4,245
+1,191
+39% +$204K 0.41% 63
2025
Q2
$466K Sell
3,054
-1,025
-25% -$158K 0.35% 77
2025
Q1
$676K Buy
4,079
+2,173
+114% +$340K 0.56% 56
2024
Q4
$276K Sell
1,906
-1,447
-43% -$224K 0.22% 96
2024
Q3
$543K Sell
3,353
-215
-6% -$34.3K 0.41% 72
2024
Q2
$522K Sell
3,568
-2,586
-42% -$385K 0.42% 73
2024
Q1
$974K Buy
6,154
+202
+3% +$32.2K 0.76% 44
2023
Q4
$933K Sell
5,952
-868
-13% -$133K 0.79% 44
2023
Q3
$1.06M Buy
6,820
+424
+7% +$70K 0.97% 28
2023
Q2
$1.06M Buy
6,396
+1,344
+27% +$217K 0.93% 29
2023
Q1
$783K Sell
5,052
-1,894
-27% -$306K 0.74% 46
2022
Q4
$1.23M Buy
+6,946
New +$1.2M 1.39% 18

Other funds holding JNJ

Northern Financial Advisors's JNJ Position: Q2 2026 in Review

Northern Financial Advisors reduced its Johnson & Johnson (JNJ) stake by 0.91% in Q2 2026, selling an estimated $10K and leaving 4,699 shares worth $1.19M. The position accounts for 0.79% of the portfolio, ranked #35.

Northern Financial Advisors first reported a position in JNJ in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.23M in Q4 2022. 4,685 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Northern Financial Advisors held 4,699 shares of Johnson & Johnson worth $1.19M as of Q2 2026.
  • Northern Financial Advisors sold 43 Johnson & Johnson shares in Q2 2026, an estimated $10K.
  • Johnson & Johnson made up 0.79% of Northern Financial Advisors's portfolio in Q2 2026, its #35 holding.
  • Northern Financial Advisors first reported a position in Johnson & Johnson in Q4 2022 and has held it in 15 quarters since.
  • Northern Financial Advisors's Johnson & Johnson position peaked at $1.23M in Q4 2022.
  • 4,685 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Northern Financial Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.